Restoration of miR-648 overcomes 5-FU-resistance through targeting ET-1 in gastric cancer cells in-vitro
Parsa AliabadiDepartment of Immunology and Biology, Tehran University of Medical Sciences, Tehran, Islamic Republic of IranMaryam SadriDepartment of Internal Medicine, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of IranGoli SiriDepartment of Internal Medicine, Amir Alam Hospital, Tehran University of Medical Sciences, Tehran, Islamic Republic of IranFarnoosh EbrahimzadehDepartment of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of IranYalda YazdaniImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of IranА.М. ГусаровDepartment of Maxillofacial Surgery, I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University), Moscow, RussiaSahar Afzali KharkoueiFaculty of Medicine, Kerman University of Medical Sciences, Kerman, Islamic Republic of IranFatemeh AsadiDepartment of Genetics, Marvdasht Branch, Islamic Azad University, Marvdasht, Islamic Republic of IranAli AdiliSenior Adult Oncology Department, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA; Department of Oncology, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of IranAmirhossein MardiDepartment of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of IranHamed MohammadiNon-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Islamic Republic of Iran; Department of Immunology, School of Medicine, Alborz University of Medical Sciences, Karaj, Islamic Republic of Iran. Electronic address: [email protected]
2022en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba